Manufacturing
Trust us for unparalleled expertise in pharmaceutical raw materials and pharmaceutical intermediates
About TianmingOur comprehensive range includes Cardiovascular, DiabetesAnti-Tumor, and Anti-Aging Solutions
Explore productsOur commitment to quality and excellence ensures that our pharmaceutical intermediates meet the highest standards
Explore productsSpecializes in providing tailored pharmaceutical intermediates and custom synthesis services to meet your specific requirements
Experience serviceWho We Are
Pharmaceutical raw materials and active pharmaceutical ingredients manufacturers
Tianming Pharmaceutical is a leading company in the research, development, production, and sales of new drugs. Specializing in chemical intermediates, pharmaceutical chemicals, and raw materials, we are trusted active pharmaceutical ingredient suppliers for antibiotics, cardiovascular, diabetes, anti-tumor, anti-aging, and antiviral drugs.
What We Do
Transforming Health with Premium Pharmaceutical Solutions
Advanced Drug R&D
Our team pioneers in discovering and developing new drugs, focusing on antibiotics, cardiovascular, diabetes, anti-tumor, anti-aging, and antiviral treatments.
High-Quality Manufacturing
We maintain rigorous quality control across all production processes, guaranteeing the highest standards for our chemical intermediates and pharmaceutical raw materials.
Comprehensive Global Distribution
We provide active pharmaceutical ingredients, technical consulting, collaborative R&D and other services to global customers to meet diverse market needs.
Our Products
Popular categories
Antiviral
Antiviral products and their intermediates (baloxavir fumarate, nafamostat mesylate, mupiravir, etc.)
Diabetes
Diabetes API and their intermediates (alogliptin, linagliptin, empagliflozin, etc.)
Anti-tumor
Anti-tumor API and their intermediates (ibrutinib, baricitinib, tofacitinib, etc.)
Cardiovascular
Cardiovascular API and their intermediates (LCZ696, AHU377 calcium salt, etc.)
What's News
Latest News at Tianming
Elemental Impurities (ICH Q3D) in Pharmaceutical Intermediates: A Buyer’s Guide
This guide explains the four element classes, the 30% control threshold that determines whether routine testing is required, the difference between ICP-MS and ICP-OES analytical methods, and five red flags on supplier COAs that signal inadequate elemental impurity control.
Chiral Purity and Enantiomeric Excess (ee%) in Pharmaceutical Intermediates
This guide explains what ee% measures, why it differs from optical purity, how chiral HPLC validates stereochemical integrity, and which COA fields separate genuine process control from cosmetic data.
Empagliflozin Intermediate Sourcing: Buyers Guide
This buyer’s guide maps the Boehringer Ingelheim synthesis route, identifies four commercially critical intermediates with CAS numbers, explains why six chiral centers create six separate quality checkpoints.
